NL-OMON54628
Completed
Not Applicable
Effectiveness and cost-effectiveness of monitoring spondyloarthritis with the integrated eHealth system SpA-Net: a randomized controlled trial - Telemonitoring with SpA-Net (TeleSpA)
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- niversiteit Maastricht
- Enrollment
- 200
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Adult patient (18\+ years)
- •Diagnosis of SpA according to treating physician
- •At least 2 years of disease duration, to be familiar with signs, symptoms,
- •and medication
- •Stable disease, defined as being in a patient acceptable symptom state
- •according to patient AND treating physician (36\) AND no treatment change
- •expected in the next few months
- •Access to a computer, tablet and/or smartphone for the entire duration of the
Exclusion Criteria
- •Insufficient mastery of Dutch language
- •Incompetent to act for oneself
- •Limited life expectancy
- •Ongoing (or planned) pregnancy during the study period
- •Patients participating in other research project(s), with an exception for
- •strictly observational studies that do not entail additional healthcare
- •utilization and/or professional absenteeism.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Telemonitoring with SpA-NetNL-OMON25783ReumaNederland200
Not yet recruiting
Not Applicable
Effectiveness and cost-utility of telemonitoring lab results and e-consultations in rheumatoïd artritis.Rheumatoïd arthritis10003816NL-OMON52237Maasstadziekenhuis142
Active, not recruiting
Not Applicable
Efficacy and Cost Effectiveness of Remote Monitoring in Patients with Implantable Loop RecordersArrhythmiaCardiovascular - Other cardiovascular diseasesACTRN12621000089831niversity of Adelaide95
Completed
Not Applicable
Cost effectiveness analysis Telemonitoring in Heart Failureheart failure - heart decompensation10082206NL-OMON30939Academisch Ziekenhuis Maastricht390
Completed
Phase 1
The Efficacy of Telemonitoring and Integrated Personalized Diabetes Management (iPDM) in People with Insulin-treated Type 2 Diabetes MellitusDMDM, TelemedicineTCTR20220628003Roche147